Rossing P, Filippatos G, Agarwal R, Anker SD, Pitt B, Ruilope LM, Chan JCN, Kooy A, McCafferty K, Schernthaner G, et al
10.1016/S2213-8587(19)30249-9 39 LawrenceE
Prices are subject to change and personalized prices will be provided upon consultation
, L- ,
Studies have shown that GLP-1R agonists not only promote insulin secretion and exert glucose-lowering effects but also effectively delay gastric emptying, reduce intestinal motility, activate neural pathways in the hypothalamus and appetite regulation areas, resulting in decreased appetite and reduced food intake, thus treating obesity
Summary: A Tool, Not a Magic Wand Berberine is interesting because it targets metabolic pathways and may improve some cardiometabolic markers